Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
ยฃ0.46 B
Marketcap
ยฃ13.28
Share price
-0.91%
Change (1 day)
-46.98%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ51.24 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are ยฃ51.24 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ36.31 M7.82%
2024-12-31ยฃ33.67 M9.81%
2023-12-31ยฃ30.66 M